409 related articles for article (PubMed ID: 32183152)
21. Therapeutic potential of astaxanthin and superoxide dismutase in Alzheimer's disease.
Balendra V; Singh SK
Open Biol; 2021 Jun; 11(6):210013. PubMed ID: 34186009
[TBL] [Abstract][Full Text] [Related]
22. Antioxidant therapies for Alzheimer's disease.
Feng Y; Wang X
Oxid Med Cell Longev; 2012; 2012():472932. PubMed ID: 22888398
[TBL] [Abstract][Full Text] [Related]
23. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease.
Behl C
Cell Tissue Res; 1997 Dec; 290(3):471-80. PubMed ID: 9369525
[TBL] [Abstract][Full Text] [Related]
24. Sex-dependent co-occurrence of hypoxia and β-amyloid plaques in hippocampus and entorhinal cortex is reversed by long-term treatment with ubiquinol and ascorbic acid in the 3 × Tg-AD mouse model of Alzheimer's disease.
Frontiñán-Rubio J; Sancho-Bielsa FJ; Peinado JR; LaFerla FM; Giménez-Llort L; Durán-Prado M; Alcain FJ
Mol Cell Neurosci; 2018 Oct; 92():67-81. PubMed ID: 29953929
[TBL] [Abstract][Full Text] [Related]
25. Evidence that amyloid beta-peptide-induced lipid peroxidation and its sequelae in Alzheimer's disease brain contribute to neuronal death.
Butterfield DA; Castegna A; Lauderback CM; Drake J
Neurobiol Aging; 2002; 23(5):655-64. PubMed ID: 12392766
[TBL] [Abstract][Full Text] [Related]
26. Dl-3-n-butylphthalide-induced upregulation of antioxidant defense is involved in the enhancement of cross talk between CREB and Nrf2 in an Alzheimer's disease mouse model.
Wang CY; Wang ZY; Xie JW; Wang T; Wang X; Xu Y; Cai JH
Neurobiol Aging; 2016 Feb; 38():32-46. PubMed ID: 26827641
[TBL] [Abstract][Full Text] [Related]
27. Mitochondrial Pharmaceutics: A New Therapeutic Strategy to Ameliorate Oxidative Stress in Alzheimer's Disease.
Ajith TA; Padmajanair G
Curr Aging Sci; 2015; 8(3):235-40. PubMed ID: 25986626
[TBL] [Abstract][Full Text] [Related]
28. Role of antioxidants and a nutrient rich diet in Alzheimer's disease.
Veurink G; Perry G; Singh SK
Open Biol; 2020 Jun; 10(6):200084. PubMed ID: 32543351
[TBL] [Abstract][Full Text] [Related]
29. Mitochondrial dysfunction in the APP/PSEN1 mouse model of Alzheimer's disease and a novel protective role for ascorbate.
Dixit S; Fessel JP; Harrison FE
Free Radic Biol Med; 2017 Nov; 112():515-523. PubMed ID: 28863942
[TBL] [Abstract][Full Text] [Related]
30. Simultaneous activation of Nrf2 and elevation of antioxidant compounds for reducing oxidative stress and chronic inflammation in human Alzheimer's disease.
Prasad KN
Mech Ageing Dev; 2016 Jan; 153():41-7. PubMed ID: 26811881
[TBL] [Abstract][Full Text] [Related]
31. Vitamin C restores behavioral deficits and amyloid-β oligomerization without affecting plaque formation in a mouse model of Alzheimer's disease.
Murakami K; Murata N; Ozawa Y; Kinoshita N; Irie K; Shirasawa T; Shimizu T
J Alzheimers Dis; 2011; 26(1):7-18. PubMed ID: 21558647
[TBL] [Abstract][Full Text] [Related]
32. Redox regulation of heat shock protein expression in aging and neurodegenerative disorders associated with oxidative stress: a nutritional approach.
Calabrese V; Scapagnini G; Colombrita C; Ravagna A; Pennisi G; Giuffrida Stella AM; Galli F; Butterfield DA
Amino Acids; 2003 Dec; 25(3-4):437-44. PubMed ID: 14661103
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Drp1 Ameliorates Synaptic Depression, Aβ Deposition, and Cognitive Impairment in an Alzheimer's Disease Model.
Baek SH; Park SJ; Jeong JI; Kim SH; Han J; Kyung JW; Baik SH; Choi Y; Choi BY; Park JS; Bahn G; Shin JH; Jo DS; Lee JY; Jang CG; Arumugam TV; Kim J; Han JW; Koh JY; Cho DH; Jo DG
J Neurosci; 2017 May; 37(20):5099-5110. PubMed ID: 28432138
[TBL] [Abstract][Full Text] [Related]
34. A Novel Peroxidase Mimics and Ameliorates Alzheimer's Disease-Related Pathology and Cognitive Decline in Mice.
Xu J; Wang K; Yuan Y; Li H; Zhang R; Guan S; Wang L
Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30352982
[TBL] [Abstract][Full Text] [Related]
35. Vitamin E for Alzheimer's disease and mild cognitive impairment.
Isaac MG; Quinn R; Tabet N
Cochrane Database Syst Rev; 2008 Jul; (3):CD002854. PubMed ID: 18646084
[TBL] [Abstract][Full Text] [Related]
36. Antioxidant clinical trials in mild cognitive impairment and Alzheimer's disease.
Mecocci P; Polidori MC
Biochim Biophys Acta; 2012 May; 1822(5):631-8. PubMed ID: 22019723
[TBL] [Abstract][Full Text] [Related]
37. Effects of multifunctional antioxidants on mitochondrial dysfunction and amyloid-β metal dyshomeostasis.
Kawada H; Blessing K; Kiyota T; Woolman T; Winchester L; Kador PF
J Alzheimers Dis; 2015; 44(1):297-307. PubMed ID: 25227315
[TBL] [Abstract][Full Text] [Related]
38. Antioxidant approaches for the treatment of Alzheimer's disease.
Lee HP; Zhu X; Casadesus G; Castellani RJ; Nunomura A; Smith MA; Lee HG; Perry G
Expert Rev Neurother; 2010 Jul; 10(7):1201-8. PubMed ID: 20586698
[TBL] [Abstract][Full Text] [Related]
39. AdipoRon improves cognitive dysfunction of Alzheimer's disease and rescues impaired neural stem cell proliferation through AdipoR1/AMPK pathway.
Liu B; Liu J; Wang JG; Liu CL; Yan HJ
Exp Neurol; 2020 May; 327():113249. PubMed ID: 32070713
[TBL] [Abstract][Full Text] [Related]
40. Carbenoxolone Reverses the Amyloid Beta 1-42 Oligomer-Induced Oxidative Damage and Anxiety-Related Behavior in Rats.
Sharma S; Sharma N; Saini A; Nehru B
Neurotox Res; 2019 Apr; 35(3):654-667. PubMed ID: 30402773
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
